A Model to Predict Risk of Hyperkalemia in Patients with Chronic Kidney Disease Using a Large Administrative Claims Database

BACKGROUND: Chronic kidney disease (CKD) is responsible for substantial clinical and economic burden. Drugs that inhibit the renin-angiotensin-aldosterone system inhibitors (RAASi) slow CKD progression in many common clinical scenarios. Guideline-directed medical therapy requires maximal recommended...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Ajay, Alvarez, Paula J, Woods, Steven D, Dai, Dingwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665575/
https://www.ncbi.nlm.nih.gov/pubmed/33204127
http://dx.doi.org/10.2147/CEOR.S267063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665575/
https://www.ncbi.nlm.nih.gov/pubmed/33204127
http://dx.doi.org/10.2147/CEOR.S267063

Ejemplares similares